EpiBiologics Funding & Investors
EpiBiologics develops first-in-class antibody based targeted therapies against membrane and extracellular proteins that drive underlying disease biology.
epibiologics.comTotal Amount Raised: $73,000,000
EpiBiologics Funding Rounds
Series A
$23,000,000
Series A Investors
Codon CapitalTaiho VenturesDigitalis VenturesMubadala Capital VenturesPolaris PartnersVivo CapitalGVSeries A
$50,000,000
Series A Investors
Mubadala Capital VenturesPolaris PartnersVivo CapitalGV
Funding info provided by Diffbot.